The QualityStocks Daily Monday, March 10th, 2025

Today's Top 3 Investment Newsletters

Schaeffer's(RDFN) $9.7700 +67.87%

Premium Stock Alerts(CKPT) $3.9800 +61.13%

360 Wall Street(MLYS) $14.9600 +42.21%

The QualityStocks Daily Stock List

Trevi Therapeutics (TRVI)

QualityStocks, MarketClub Analysis, MarketBeat, TradersPro and Streetwise Reports reported earlier on Trevi Therapeutics (TRVI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Trevi Therapeutics Inc. (NASDAQ: TRVI) is a clinical-stage biopharmaceutical firm that is en-gaged in developing and commercializing therapies for the treatment of severe neurologically mediated conditions.

The firm has its headquarters in New Haven, Connecticut and was incorporated in March 2011 by Jennifer L. Good and Thomas R. Sciascia. It serves patients in the United States.

The company is party to a license agreement with Rutgers, which involves the development and commercialization of products that incorporate nalbuphine for any human or animal use. It is also party to a license agreement with Endo Pharmaceuticals Inc., which entails the development and commercialization of products that incorporate nalbuphine hydrochloride in their formulation.

The enterprise develops an investigational therapy known as Haduvio, for the treatment of severe neurologically mediated conditions that target the peripheral and central nervous systems. Ha-duvio is an oral extended release nalbuphine formulation. Nalbuphine has a dual mechanism of action, acting as both an agonist to the kappa opioid receptor and an antagonist to the body’s mu opioid receptor. The formulation is undergoing phase 2b/3 clinical trials, evaluating its effective-ness in treating chronic kidney disease-associated with pruritus, chronic pruritus, levodopa-induced dyskinesia in patients with Parkinson’s disease and chronic cough in patients suffering from idiopathic pulmonary fibrosis. These indications share a common pathophysiology which is mediated through opioid receptors in the peripheral and central nervous systems.

Trevi Therapeutics (TRVI), closed Monday's trading session at $6.07, up 41.1628%, on 57,705,813 volume. The average volume for the last 3 months is 22,610 and the stock's 52-week low/high is $2.3/$7.39.

Sonoma Pharmaceuticals (SNOA)

QualityStocks, StockMarketWatch, MarketClub Analysis, TradersPro, MarketBeat, The Stock Dork, StockEarnings, InvestorPlace, BUYINS.NET, AwesomeStocks, The Online Investor and StreetInsider reported earlier on Sonoma Pharmaceuticals (SNOA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) (FRA: O8Z3) is a specialty pharmaceutical firm that is focused on the development and production of stabilized hypochlorous acid products for different applications, including oral care, eye care, animal health care, wound care and der-matological conditions.

The firm has its headquarters in Woodstock, Georgia and was incorporated in April 1999 by Lin-da Alimi and Hojabr Alimi. Prior to its name change in December 2016, the firm was known as Oculus Innovative Sciences Inc. The firm serves consumers around the globe.

The enterprise’s product portfolio is made up of a HOCl-based product dubbed Acuicyn, to help relieve inflammation and itching around the eye; SebuDerm, for relief and management of itch-ing, pain and burning associated with seborrheic dermatitis and seborrhea; Celacyn gel, which has been developed to promote healing through the management of old and new scars; a HOCl-based prescription product dubbed Levicyn, which has been developed to manage pain, itching and burning; and an antimicrobial facial cleanser dubbed Epicyn. It also develops Lasercyn gel to manage skin irritations; an atopic dermatitis hydrogel dubbed Pediacyn; a treatment of topical mild to moderate acne dubbed Gramaderm; a HOCl-based solution known as MicrocynAH, for relief of scratches, hot spots and irritated skin in animals. In addition to this, the enterprise de-velops Sinudox for nasal irrigation and a surface disinfectant known as Microsafe. It generates revenue from product sales around the globe.

Sonoma Pharmaceuticals (SNOA), closed Monday's trading session at $2.79, up 40.201%, on 37,838,837 volume. The average volume for the last 3 months is 9,787,516 and the stock's 52-week low/high is $1.9/$9.374.

SciSparc Ltd (SPRC)

QualityStocks, ProTrader, Premium Stock Alerts, Prism MarketView, Broad Street, The Online Investor, MarketClub Analysis, BeatPennyStocks, Epic Stock Picks, Fierce Analyst, Jeff Bishop, PennyStockProphet, Penny Picks, StockStreetWire, The Stock Dork, Wolf of Penny Stocks, StockWireNews, Small Cap Firm, Small Caps and OTCtipReporter reported earlier on SciSparc Ltd (SPRC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SciSparc Ltd (NASDAQ: SPRC) is a specialty clinical-stage pharmaceutical firm that is focused on the development of drugs based on cannabinoid molecules.

The firm has its headquarters in Tel Aviv, Israel and was incorporated in 2004. Prior to its name change in January 2021, the firm was known as Therapix Biosciences Ltd. The firm serves con-sumers around the globe.

The company is party to an agreement with the Sheba Fund for Health Services and Research, which entails performing a pre-clinical trial evaluating the effectiveness of SCI-210 in the treat-ment of status epilepticus. It is also party to an agreement with Procaps, which entails the devel-opment and commercial manufacture of CannAmide in softgel capsule form and SCI-110. The company also has an agreement with The Israeli Medical Center for Alzheimer's, which involves carrying out a phase 2a clinical trial evaluating the effectiveness, tolerability and safety of SCI-110 in patients with Alzheimer’s disease.

The enterprise’s drug development programs include SCI-210, for the treatment of epilepsy and autism spectrum disorder; SCI-160 for the treatment of pain; and SCI-110, to treat obstructive sleep apnea and Tourette syndrome.

SciSparc Ltd (SPRC), closed Monday's trading session at $0.4, up 25.1564%, on 114,107,844 volume. The average volume for the last 3 months is 6,556,795 and the stock's 52-week low/high is $0.197/$3.63.

Zion Oil & Gas, Inc. (ZNOG)

QualityStocks reported earlier on Zion Oil & Gas, Inc. (ZNOG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Zion Oil & Gas, Inc. operates as an oil and gas exploration company in Israel. It explores for oil and gas onshore in Israel on its 99,000-acre Megiddo-Jezreel license area. Fundamentally, it is exploring for Isra-el’s Political and Economic Independence. Established in 2000, Zion Oil & Gas has its corporate head-quarters in Dallas, Texas. It also has its Israel office in Caesarea. The Company’s shares trade on the OTCQB.

Zion Oil & Gas’ vision is to find oil and/or natural gas in Israel. The Company’s Founder and Chairman, Mr. John Brown, provides the broad vision and goals for Zion Oil & Gas. The Company says that the initi-atives taken by its Management as it explores for oil and gas in Israel are founded on modern science and good business practices. Zion’s oil and gas exploration activities are supported by suitable geological, geophysical, as well as other science-based studies and surveys.

Mr. Brown has wide-ranging management, marketing, and sales experience, serving as Corporate Direc-tor of Purchasing at GTE Valeron, a subsidiary of GTE Corporation from 1966 to 1986. He was Corporate Director of Procurement at Magnetek, Inc. during 1988-89. Until 2012, Mr. Brown was also an Officer and Director of M&B Holding, Inc.

Zion Oil & Gas, Inc. (ZNOG), closed Monday's trading session at $0.2335, up 22.1873%, on 5,554,470 volume. The average volume for the last 3 months is 659,125 and the stock's 52-week low/high is $0.03/$0.2699.

Texas Mineral Resources Corp. (TMRC)

QualityStocks, InvestorIntel, RedChip, TradersPro, TopPennyStockMovers, OTC Markets Group and MarketBeat reported earlier on Texas Mineral Resources Corp. (TMRC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Texas Mineral Resources Corp. is targeting the heavy rare earths, technology metals, and an assortment of industrial minerals. An exploration Company, its emphasis is to develop and commercialize its Round Top heavy rare earth, technology metals, and industrial minerals project located in Hudspeth County, Texas. The Company previously went by the name Texas Rare Earth Resources Corp. It changed its name to Texas Mineral Resources Corp. in March of 2016. Incorporated in 1970, Texas Mineral Resources is headquartered in Sierra Blanca, Texas. The Company lists on the OTC Markets Group’s OTCQB.

Texas Mineral Resources believes it is crucial to re-establish the United States as the leader in technology, production, and refining of the strategically critical heavy rare earth elements. The Company’s intention is to be the secure supplier of these elements, which are the foundation of the United States’ defense and technological infrastructure. Furthermore, it plans on developing alternative sources of strategic minerals via the processing of coal waste and other related materials.

Texas Mineral Resources’ flagship Round Top project is approximately 85 miles southeast of El Paso, Tex-as. The Company holds 19-year renewable leases from the State of Texas on 950 acres encompassing Round Top and additional prospecting permits on adjacent areas covering an additional 9,345 acres. Round Top has ease of access to infrastructure (Electricity, Highway, Natural Gas, Rail, Water). It is posi-tioned entirely on State Land (No BLM, No Forest Service).

Round Top is a large, Porphyry-Style REE Deposit (Massive Tonnage/Economies of Scale, Rich in CREE/HREE). Also, it has favorable mineralization (Yttrofluorite & Yttrocerite, Evenly Disseminated, Min-imal Stripping Required). Texas Mineral Resources is developing its Round Top heavy rare earth critical minerals project along with its funding and development partner USA Rare Earth LLC.

Texas Mineral Resources Corp. (TMRC), closed Monday's trading session at $0.55, up 7.8431%, on 261,667 volume. The average volume for the last 3 months is 95,860 and the stock's 52-week low/high is $0.199/$0.5748.

Aspira Women’s Health (AWH)

TradersPro, StreetInsider, MarketClub Analysis, QualityStocks, Zacks, Marketbeat.com, The Street, MarketBeat, The Online Investor, Investopedia, SmarTrend Newsletters, Daily Trade Alert, The Street Report, TopStockAnalysts, Coattail Investor, Daily Wealth, Hit and Run Candle Sticks, INO.com Market Report, InvestmentHouse, Prism MarketView, Street Insider, StreetAuthority Daily, Schaeffer's and Investors Alley reported earlier on Aspira Women’s Health (AWH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aspira Women's Health Inc. (NASDAQ: AWH) (FRA: CUL1) is a biotech firm that is focused on the discovery, development and commercialization of bio-analytical and diagnostic solutions that assist clinicians in diagnosing, treating and improving gynecologic health outcomes for women.

The firm has its headquarters in Austin, Texas and was incorporated in 1993, on December 9th. Prior to its name change in June 2020, the firm was known as Vermillion Inc. It operates as part of the scientific research and development services industry and serves consumers in the state of Tex-as and across the U.S. The firm has four companies in its corporate family.

The company is party to a strategic alliance with Quest Diagnostics Inc. It is also party to an agreement with the Medical University Lodz to assess microRNA technology in combination with its technologies, for the development of detection tests for ovarian cancer. This is in addition to its agreements with Brigham Women’s Hospital and the Dana Farber Cancer Institute. Furthermore, the company is party to a collaborative research agreement with Baylor Genetics, which entails the co-development of new ovarian cancer detection tests. The company serves mainly physicians, hospital labs and physician offices.

The enterprise’s product pipeline is made up of a genetic test developed to detect gynecologic can-cer dubbed Aspira GenetiX; and its Ova1PLUS, Overa and OVA1 products, which have been de-veloped to detect a woman’s risk of ovarian malignancies.

Aspira Women’s Health (AWH), closed Monday's trading session at $0.198, up 7.027%, on 1,268,593 volume. The average volume for the last 3 months is 12,351,720 and the stock's 52-week low/high is $0.1429/$3.92.

Arqit Quantum (ARQQ)

StockEarnings, MarketClub Analysis, Early Bird, QualityStocks, Money Wealth Matters, Marketbeat.com, StocksEarning, Schaeffer's, MarketBeat, Investors Underground, InvestorPlace and 360 Wall Street reported earlier on Arqit Quantum (ARQQ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Arqit Quantum Inc. (NASDAQ: ARQQ) is engaged in the provision of cybersecurity services through satellite and terrestrial platforms.

The firm has its headquarters in London, the United Kingdom and was incorporated in 2021, on April 26th by David James Bestwick and David John Williams. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers in the United Kingdom.

The company mission is to use its transformational quantum encryption technology to keep safe the data of governments, enterprises and citizens. It operates in one segment; the provision of cybersecurity services via satellite and terrestrial platforms. The com-pany generates the majority of its revenues from the UK.

The enterprise supplies quantum encryption platform-as-a-service, which makes the communications links of networked devices secure against cyber attacks. Its products include QuantumCloud, a Platform as a Service that creates unbreakable software en-cryption keys. These unbreakable software encryption keys are easy to use and have universal application to every edge device and cloud machine, as well as unique quan-tum encryption technology which makes the communications links of any networked device secure against cyber attack. This platform also solves the problems of legacy encryption techniques. The enterprise also offers maintenance and support, and other related professional services.

Arqit Quantum (ARQQ), closed Monday's trading session at $11.25, off by 10.7851%, on 183,773 volume. The average volume for the last 3 months is 212,143,639 and the stock's 52-week low/high is $3.38/$7.76.

Rare Element Resources (REEMF)

MarketBeat, QualityStocks, TradersPro and InvestorIntel reported earlier on Rare Element Resources (REEMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rare Element Resources Ltd. (OTCQB: REEMF) is a strategic materials firm engaged in explor-ing for mineral properties, with a focus on rare earth products for technology, energy and defense applications.

The firm has its headquarters in Littleton, Colorado and was incorporated in 1999, on June 3rd by Mark Thomas Brown. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm serves consumers around the globe, with a focus on those in the United States.

The company operates through the exploration of mineral properties segment. It is focused on delivering strategic materials to technology industries by advancing plans to develop the Bear Lodge Property, located in northeast Wyoming. This property is located 7 air miles (11km) or 12 road miles (19km) northwest of the town of Sundance, Wyoming. The property contains 2 pro-jects; the Bear Lodge Critical Rare Earth (REE) Project, which is located near the town of Sun-dance in northeast Wyoming; and the Sundance Gold Project. The Bear Lodge REE Project comprises of the Bull Hill mineral district, inclusive of the Bull Hill and Whitetail Ridge deposits and the exploration targets of East Taylor and Carbon. The identified REE deposits and occur-rences within the Bear Lodge Property alkaline complex are contained within the company’s block of unpatented lode mining claims.

Rare Element Resources (REEMF), closed Monday's trading session at $0.72794, up 5.4986%, on 592,039 volume. The average volume for the last 3 months is 10,491,448 and the stock's 52-week low/high is $0.1446/$1.1535.

Xiao-I Corp (AIXI)

QualityStocks and InvestorsUnderground reported earlier on Xiao-I Corp (AIXI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Xiao-I Corporation (NASDAQ: AIXI) is anAI industrialization company that offers an extensive range of business solutions and services in artificial intelligence.

The firm has its headquarters in Shanghai, China and was incorporated in 2018. It operates as part of the software-application industry, under the technology sector. The firm mainly serves consumers in the People’s Republic of China.

The company operates through its subsidiary, Shanghai Xiao-i Robot Technology Company Lim-ited. Its platform combines technologies like Affective Computing, Natural Language Processing, Voice and Image recognition, Machine Learning, Data Intelligence, and Hyper- automation. The company generates revenue from the sale of software products and services, M&S services, and the sale of cloud platform products.

Xiao-1 provides a knowledge fusion platform which integrates Q&A, documents, multimedia, information forms, business processes, and knowledge graphs; a conversational AI platform that uses deep learning, data enhancement, active learning technologies for dialog management and context processing mechanisms; an intelligence voice platform to enhance intelligent speech solu-tions; and a hyper-automation platform that integrates technologies, such as OCR, NLP, and vis-ualized data mining and analysis that enables users to realize business and process automation. It also offers a cloud platform that integrates speech recognition, image recognition, NLP, and data analysis capabilities; and an intelligent construction support platform which offers parsing, recon-struction, visualization, and multi-dimensional analysis of construction drawings. In addition to this, the enterprise provides intelligent hardware support platform which provides the framework of signal collection, processing, analysis, prediction, and others; and metaverse platform that de-velops virtual digital human.

The company is planning to expand its enterprise LLM solutions into the United States in an ef-fort to meet the dynamic needs of American corporations seeking robust and affordable AI ser-vices. This may in turn help generate additional value for its shareholders and bolster its overall growth.

Xiao-I Corp (AIXI), closed Monday's trading session at $3.77, off by 11.5023%, on 82,145 volume. The average volume for the last 3 months is 175,562 and the stock's 52-week low/high is $2.0628/$19.8.

Momo Inc. (MOMO)

QualityStocks, StocksEarning, StockEarnings, MarketClub Analysis, InvestorPlace, Schaeffer's, Marketbeat, Market Intelligence Center Alert, Zacks, The Street, Trades Of The Day, Kiplinger Today, Daily Trade Alert, StreetInsider, FreeRealTime, The Street Report, Marketbeat.com, BUYINS.NET, The Online Investor, INO.com Market Report, ChineseWire, TipRanks, Louis Navellier, TradersPro, Trading Concepts, Wealth Insider Alert, StreetAuthority Daily, TopStockAnalysts, Investopedia, Money Morning, DividendStocks, Daily Wealth, PennyDoctor, Greenbackers, StockMarketWatch, StocksImpossible, Street Insider, OTCBB Journal, Early Bird, First Penny Picks, ChartAdvisor, Barchart, CrashTrade, Investing Signal, InvestmentHouse, Jason Bond, AskSlapper, Orbit Stocks, Profit Confidential, Promotion Stock Secrets, Short Term Wealth, Terry's Tips, The Best Newsletters, The Stock Dork and One Hot Stock reported earlier on Momo Inc. (MOMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A panel of entertainment industry experts believes that artificial intelligence (AI) is poised to revolutionize movie production. AI and its impact on entertainment was one of the main topics of discussion at Mip London, an event that brought together multiple leading production executives.

Discussions centered on AI in the entertainment industry all came to a similar conclusion; artificial intelligence has the potential to transform how the entertainment sector makes movies and TV shows. The executives shared insights on how content creation is transforming thanks to AI and highlighted how the revolutionary technology can help independent producers gain a competitive edge over traditional studios.

The Connected Set’s founder Jason Mitchell presented an animation tool dubbed Storyboarder.ai that used generative artificial intelligence to turn scripts into storyboards. According to Mitchell, the $50-a-month tool turns written scripts into storyboards which are then forwarded to human animators to do the actual animation. Mitchell says the ultimate goal is to have Storyboarder.ai go even further and do the animations themselves.

Digital production company Particle6 Productions is going to even greater lengths to implement artificial intelligence into entertainment. CEO Eline Van Der Velden says her firm has begun generating entire short films using AI, allowing Particle6 to cut production costs by a whopping 90% compared to conventional movie-making methods.

One of the main reasons production companies are adopting artificial intelligence-powered tools is to lower production costs. As such, small, independent production houses with limited capital are turning to AI in larger numbers.

Armoza Formats CEO Avi Armoza notes that with less cash flowing into the entertainment industry, everyone is seeking more cost-efficient ways to make movies and television shows. For instance, Armoza said, his production firm’s game show ‘Family Piggy Bank’ uses computer-generated images (CGI) to drastically reduce the money it spends building sets.

The use of sets that are entirely computer-generated allows Armoza Formats to use AI during post-production to generate different sets at a relatively low cost. Panelists at Mip London were especially optimistic about how artificial intelligence could help small production houses compete with established industry giants like Disney or Universal Studios.

Van Der Velden said Indie producers were better positioned to leverage AI compared to larger companies as they aren’t ‘ring-fenced’ or tied down by enterprise agreements.

Mitchell noted that while broadcasters have been resistant to implementing artificial intelligence in live productions, the technology is more accepted in development as well as post-production.

Furthermore, he said that while we can expect AI to reduce the number of job opportunities available to humans, the sheer volume of content AI can allow the industry to produce presents major opportunities for people in the content industry.

It remains to be seen how enterprises like Momo Inc. (NASDAQ: MOMO) that have interests in the TV and movie production space will leverage AI to improve their service offerings.

Momo Inc. (MOMO), closed Monday's trading session at $7.31, off by 4.4444%, on 934,654 volume. The average volume for the last 3 months is 322,930 and the stock's 52-week low/high is $4.79/$8.38.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, PsychedelicNewsWire, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, Prism MarketView, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The American embassy in Peru has warned Americans against taking traditional psychedelics like the ayahuasca brew while in Peru. They cautioned that this mixture contains DMT, which is a potent hallucinogen that’s illegal in the U.S. and several other countries.

The embassy officials added that consuming the brew or even kambo, a psychoactive substance extracted from certain frogs, can trigger adverse health effects while also elevating a person’s risk of being robbed, sexually assaulted, or being a victim of other crimes. The health alert issued by the embassy also revealed that the psychoactive substances are usually marketed to people traveling within Peru and they are said to be “spiritual cleansers” or “ceremonial drinks.”

The embassy cautioned that the groups or individuals offering these substances aren’t regulated by the government and they don’t adhere to any known safety or health practices or regulations.

The alert explains that ayahuasca has been known to cause several negative effects, such as vomiting, nausea, elevated heart rate or even death. It cites examples of Americans who were severely ill or even died last year after consuming these psychoactive substances. They say the probability of severe health complications increases because the hallucinogens are usually taken in remote locations that aren’t within easy reach of well-equipped medical facilities.

The embassy says a number of Americans have reported being robbed, sexually assaulted or injured while they were “tripping” on psychedelics at “retreats” or “healing centers.”

Americans have been going to countries in South America for long in a bid to access traditional psychedelics like ayahuasca brews. These substances have been used by traditional communities for religious and healing purposes for a number of centuries. Particularly, U.S. veterans have flocked to Peru to use these hallucinogens as a last-ditch effort to get relief from conditions like PTSD or other psychiatric issues arising from their war experiences.

The research community has also shown increasing interest in studying these substances. As a result, the DEA has been increasing its production quotas in order to avail more supplies of these substances to groups interested in conducting studies on them. It is hoped that the studies will increase our understanding of psychedelics and later yield approved treatments that can help those who aren’t responding to the existing treatments.

Entities like Compass Pathways PLC (NASDAQ: CMPS) are making progress in their efforts to develop psychedelic treatments that meet regulatory approval requirements. Hopefully, their efforts will yield results sooner rather than later.

Compass Pathways PLC (CMPS), closed Monday's trading session at $3.54, off by 5.3476%, on 1,933,586 volume. The average volume for the last 3 months is 1,179,957 and the stock's 52-week low/high is $3.165/$11.33.

Cronos Group Inc. (CRON)

InvestorPlace, Schaeffer's, QualityStocks, Kiplinger Today, MarketClub Analysis, StocksEarning, The Street, MarketBeat, Daily Trade Alert, Trades Of The Day, The Online Investor, Wealth Insider Alert, StockEarnings, Market Intelligence Center Alert, StockMarketWatch, StreetInsider, CannabisNewsWire, BUYINS.NET, The Wealth Report, Zacks, Investopedia, Top Pros' Top Picks, Stock Up Featured, Daily Profit, Cabot Wealth, InvestmentHouse, Jim Cramer, Early Bird, InsiderTrades, The Rich Investor, Money Morning, InvestorsUnderground, 24/7 Trader, TheTradingReport, VectorVest, Wall Street Window, Small Cap Firm, Stock Gumshoe and InvestorsObserver Team reported earlier on Cronos Group Inc. (CRON), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A Senate committee in Texas recently reviewed a proposed measure that seeks to prohibit all types of THC. SB 3, supported by Lieutenant Governor Dan Patrick, addresses concerns over illegal THC products being sold statewide.

Patrick argues that businesses are taking advantage of a legal loophole to sell potentially harmful substances. In 2019, Texas legalized the production and sale of hemp through the Hemp Farming Act, which allowed for cannabis plants with no more than 0.3% delta-9 THC.

Some business owners acknowledge the need for stricter regulations, such as age restrictions, but believe an outright ban is excessive. According to Jazmin Torres, proprietor of Zenblendz, a smoke shop that sells THC products, a large portion of her clientele consists of elderly folks and veterans who use the products for wellness purposes rather than for recreational purposes. She worries a comprehensive ban would kill the sector.

Hometown Hero, a marijuana wholesaler based in Austin, also voiced concerns. A company representative emphasized that their products offer a safer alternative to alcohol and warned that banning hemp-derived THC could drive sales underground, making regulation even more difficult. The company hopes to collaborate with lawmakers to ensure adult consumers and veterans can continue accessing these products responsibly.

A recent survey by the Hobby School of Public Affairs at the University of Houston examined public opinion on cannabis policies in Texas. While medical cannabis enjoys the most widespread support, there is also significant backing for more relaxed recreational use laws.

The study found that 69% of Texans favor decriminalizing cannabis possession, and 62% support legalizing recreational use and sales. Although opinions differ across political lines, a majority in both major parties back legalization, with 53% of Republicans and 71% of Democrats in favor.

Support for medical cannabis is even higher, with 79% of Texans believing it should be available with a prescription. Among Republicans, 75% endorse medical cannabis, while 86% of Democrats share this view.

Despite widespread backing for cannabis reform, more than 50% of Texans agree with the governor’s proposed ban on THC-infused consumables, which remain unregulated. The level of support varies across different groups: 61% of Republicans, 70% of Gen Z, 48% of Democrats, and 46% of baby boomers are in favor of restricting these products.

As lawmakers consider the economic and consumer impact of this proposal, the Senate State Affairs Committee will continue to assess the potential consequences of banning THC products in Texas.

The marijuana industry, including leading brands like Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) in other jurisdictions recognize that regulation is important, but lawmakers also need to find ways to regulate marijuana without stifling business.

Cronos Group Inc. (CRON), closed Monday's trading session at $1.93, off by 3.0151%, on 1,493,106 volume. The average volume for the last 3 months is 309,999 and the stock's 52-week low/high is $1.83/$3.14.

The QualityStocks Company Corner

Calidi Biotherapeutics Inc. (NYSE American: CLDI)

The QualityStocks Daily Newsletter would like to spotlight Calidi Biotherapeutics Inc. (NYSE American: CLDI).

Calidi Biotherapeutics (NYSE American: CLDI) announced positive preclinical results for its systemic RTNova platform, demonstrating effective delivery of transient gene therapy payloads to targeted tumors. The tumor-specific virotherapy has shown efficacy across more than 60 tumor cell lines, with a unique vaccinia virus strain enveloped in a human cell membrane providing protection in the bloodstream while targeting distant tumors. In preclinical models, a single dose of the tumor-selective triple knockout ("3KO") RT virus with an undisclosed immunotherapeutic payload significantly altered the tumor microenvironment, leading to complete tumor eradication in some cases. The findings support the platform's potential to revolutionize cancer treatment by enabling both tumor destruction and robust immune activation.

To view the full press release, visit https://ibn.fm/CGZoA

Calidi Biotherapeutics Inc. (NYSE American: CLDI) is a clinical-stage immuno-oncology company pioneering proprietary technology that empowers the immune system to combat cancer. Calidi’s innovative, off-the-shelf cell-based platforms use allogeneic stem cells to deliver potent oncolytic viruses (OVs) across multiple oncology indications, including high-grade glioma (brain cancers) and solid tumors. In addition, Calidi has presented a breakthrough systemic technology, RTNova, which utilizes an exteracellular enveloped virotherapy. RTNova is pre-clinical and has been extremely well-received by market analysts and large-cap biopharma – opening the door for potential collaboration.

These cell-based platforms are engineered to protect, amplify, and enhance the efficacy of oncolytic viruses, resulting in improved patient safety and potentially advancing treatment outcomes for metastatic disease. By employing a dual approach that combines OV delivery with immune activation, Calidi’s therapies aim to not only treat but potentially prevent the spread of metastatic cancers.

The company’s development pipeline leverages this technology to address pressing needs in cancers such as glioblastoma (brain cancer), metastatic melanoma, triple-negative breast cancer, head & neck cancer, and lung cancer. Calidi’s approach has shown early signals of efficacy and safety, establishing it as a distinctive player in the growing OV market, which is projected to increase significantly in value over the next decade.

Calidi is headquartered in San Diego, California.

Products

Calidi’s product pipeline includes advanced cell-based platforms targeting a variety of oncology indications, each designed to harness the power of oncolytic virotherapy for improved cancer treatment outcomes.

  • NeuroNova (CLD-101): A platform designed for treating high-grade gliomas (HGG), NeuroNova employs neuronal stem cells combined with an engineered adenovirus (CRAD-s-Pk7) to selectively target glioma cells. After a successful Phase 1 safety study in newly diagnosed HGG, NeuroNova has now progressed into Phase 1/1b trials for recurrent cases. FDA clearance for a Phase 1b/2 trial at Northwestern University was received in September 2024, with patient enrollment expected to begin in Q1 2025. This trial will utilize multiple-dose intracerebral administration to maximize safety and efficacy in newly diagnosed HGG patients.
  • SuperNova (CLD-201): Built on Calidi’s foundational technology, SuperNova utilizes an engineered Vaccinia virus (CAL1) delivered via allogeneic adipose-derived mesenchymal stem cells to target advanced solid tumors, including head & neck, triple-negative breast cancer, and soft tissue sarcomas. Early studies with autologous stem cells demonstrated both safety and promising efficacy, and Calidi plans to begin a Phase 1 trial with multiple dose regimens for SuperNova in the coming months.
  • RTNova (CLD-400): Calidi’s systemic delivery platform for lung and metastatic cancers, RTNova employs an extracellular enveloped virotherapy (envRT-01) technology for intravenous (IV) administration, simplifying the treatment process and expanding its potential applications. Currently in preclinical stages, RTNova focuses on demonstrating efficacy and safety through systemic administration. A clinical trial targeting metastatic lung cancer is anticipated for Q2 2026, using a single-arm monotherapy with dose escalation. Calidi has partnered with SIGA Technologies (NASDAQ: SIGA) to support the development of this program.

Market Opportunity

The global oncology drugs market was valued at $201.75 billion in 2023 and is projected to grow to $518.25 billion by 2032, with a CAGR of 11.3%. The oncolytic virotherapy market in particular is growing rapidly, driven by increasing approval rates and significant unmet needs.

The market for OV treatments is expected to expand from one approved product generating $150 million in the U.S. in 2021 to 6-8 approved therapies generating $2.4 billion by 2030. As a leader in OV technology, Calidi is well-positioned to address these high-demand areas in oncology.

Alongside global trends, the American Cancer Society projects nearly two million new cancer diagnoses in the U.S. in 2024, reflecting a 28% increase since 2010. This underscores the urgent need for novel therapies that not only treat disease progression but also enhance patient quality of life, reinforcing the demand for Calidi’s innovative approaches.

Management Team

Allan Camaisa, CEO, Chairman, and co-founder, is a seasoned leader with extensive experience in scaling businesses to successful exits. Mr. Camaisa previously led High Technology Solutions, growing it from two employees to over 500 with $50 million in revenue. He also served as CEO of Parallel6 Inc. and is a U.S. Naval Academy graduate with further studies at Harvard Business School.

Antonio Santidrian, Ph.D., Chief Scientific Officer, leads all research and development initiatives at Calidi and is the coinventor of the company’s CLD-201 (Supernova) and CLD-400 (RTNova) platforms. Since joining Calidi in 2015, he has applied his 20+ years of expertise in academia and biotech, focusing on anti-cancer translational research, to drive the company’s innovative drug pipeline. Before Calidi, Dr. Santidrian led translational studies at The Scripps Research Institute, advancing treatments for breast cancer metastasis, and contributed to the development of ACADRA for chronic lymphocytic leukemia (CLL) at the University of Barcelona, Spain.

Boris Minev, M.D., President of Medical and Scientific Affairs, is a renowned physician-scientist with expertise in Immuno-Oncology, stem cell biology, and oncolytic viruses. Previously, Dr. Minev served as Director of Immunotherapy and Translational Oncology at Genelux Corporation and remains an adjunct professor at the Moores UCSD Cancer Center. His background includes research at the National Cancer Institute.

Andrew Jackson, CFO, has held executive finance roles with experience in biotech and clinical-stage companies, including Eterna Therapeutics and Ra Medical Systems. Mr. Jackson holds an MSBA in Finance from San Diego State University and a BSB in Accounting from the University of Minnesota.

Calidi Biotherapeutics Inc. (NYSE American: CLDI), closed Monday's trading session at $0.7904, off by 7.0664%, on 4,340 volume. The average volume for the last 3 months is 2,095,820 and the stock's 52-week low/high is $0.58/$8.3.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

The CBD market in the United Kingdom has grown since the compound's extracts were designated as new foods in 2019. Currently, the market is valued at $850 million, with projections expecting it to hit $1 billion in a couple of years. Recently, a joint application filed by HERBL, Liverpool, and TTS Pharma, along with Bridge Farm Group, cbdMD, Mile High Labs, and Brains Bioceutical, passed the Food Standards Agency's safety evaluation phase. These applications follow three granted to Cannaray, Pureis and a separate consortium in 2024. Each adheres to the 10mg acceptable daily intake threshold for CBD, which is even lower than the 17.5mg proposed by the European Industrial Hemp Association. Some figures have argued that applications proposing higher thresholds may have a hard time passing the safety review following the recent developments. It is important to note that any detectable levels of THC in a product make it illegal in the country, unless it meets strict Exempt Product Criteria. THC is one of the two primary compounds found in marijuana, the other being CBD. Unlike THC, though, CBD does not induce a high when consumed. As jurisdictions like the UK ease their laws on CBD products, international players like Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) could explore the possibility of getting a foothold in these markets.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Monday's trading session at $0.01, up 25%, on 601 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0071/$0.06.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

Web3 is reshaping industries by introducing decentralization, transparency, and automation through blockchain technology. Unlike traditional systems that rely on intermediaries, Web3 empowers individuals with direct ownership, smart contracts, and tokenized transactions and digital asset ownership. Among the industries experiencing significant disruption are supply chain and logistics, content creation, and gaming. Traditional supply chains are often inefficient, relying on multiple intermediaries for tracking, payments, and order fulfillment. This creates delays, fraud risks, and high costs. Web3 is changing this by introducing blockchain-based tracking systems that offer a transparent and immutable ledger. All in all, Web3 is revolutionizing industries by decentralizing control and enhancing transparency. While supply chains, content creation, and gaming are seeing early adoption, challenges remain in terms of regulation, infrastructure, and market volatility. Despite this, Web3's potential to reshape digital interactions and economies is undeniable. As more industries incorporate Web3 technologies, firms like Horizon Fintex that were early adaptors are likely to have a huge advantage over those that took their time in embracing these technologies.

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & IssuanceETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance OnboardingKYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening SoftwareAMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management ToolsCustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App TechnologyOpen Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)

The QualityStocks Daily Newsletter would like to spotlight Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP).

Tonix Pharmaceuticals (NASDAQ: TNXP) has been awarded a grant from the Medical CBRN Defense Consortium (MCDC) to advance the development of TNX-801, a recombinant horsepox virus-based live vaccine for mpox and smallpox. The funding will support market analysis, target market identification, and commercialization planning for both private and government sectors. TNX-801 is designed as a single-dose vaccine with long-term protection and improved tolerability compared to older vaccinia-based vaccines. Preclinical studies have demonstrated its effectiveness against monkeypox, offering potential global benefits amid ongoing outbreaks of clade I mpox.

To view the full press release, visit https://ibn.fm/BXOqT

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is a fully-integrated biopharmaceutical company dedicated to developing, licensing, and commercializing innovative therapeutics aimed at treating and preventing human diseases and alleviating suffering. The company’s development portfolio is primarily focused on central nervous system (CNS) disorders, with its lead product candidate, TNX-102 SL, showing significant promise for the management of fibromyalgia. With two successful Phase 3 studies completed, Tonix is preparing to submit a New Drug Application (NDA) to the FDA in the second half of 2024 for TNX-102 SL, which has also been granted Fast Track designation. In addition to fibromyalgia, TNX-102 SL is being developed to treat acute stress reactions, further broadening its therapeutic potential.

Tonix’s CNS portfolio also includes TNX-1300, a biologic designed to treat cocaine intoxication, which has been granted Breakthrough Therapy designation by the FDA. This designation underscores the urgency and significance of developing an effective treatment for cocaine intoxication, a critical need in the healthcare system. Beyond CNS disorders, Tonix is expanding its immunology portfolio with the development of TNX-1500, a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154). TNX-1500 is being developed for the prevention of allograft rejection and the treatment of autoimmune diseases, highlighting Tonix’s commitment to addressing complex and challenging medical conditions.

In addition to its robust pipeline, Tonix has an established commercial presence through its subsidiary, Tonix Medicines, which markets Zembrace® SymTouch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg for the treatment of acute migraine in adults. The company’s diverse portfolio, spanning CNS disorders, immunology, rare diseases, and infectious diseases, positions Tonix as a leader in biopharmaceutical innovation, with a strong focus on developing therapies that address unmet medical needs and improve patient outcomes.

TNX-102 SL

TNX-102 SL is a groundbreaking, non-opioid, non-addictive investigational drug developed by Tonix Pharmaceuticals for the management of fibromyalgia where patients suffer chronic musculoskeletal pain, sleep deprivation, fatigue and mood changes. This patented sublingual formulation of cyclobenzaprine hydrochloride has demonstrated remarkable efficacy in clinical trials, including the recent RESILIENT Phase 3 trial, where it achieved highly statistically significant results in reducing daily pain compared to placebo (p=0.00005). The drug also showed significant improvements in sleep quality, fatigue reduction, and overall fibromyalgia symptoms and function across all key secondary endpoints. With similar success in the earlier RELIEF Phase 3 trial, TNX-102 SL is positioned as a promising new treatment option for fibromyalgia, particularly given its favorable safety profile, where the most common side effect was mild and self-limiting tongue or mouth numbness.

Recently granted Fast Track Designation by the FDA, TNX-102 SL is on course for a New Drug Application (NDA) submission in the second half of 2024. This designation highlights the urgent need for new fibromyalgia treatments and underscores the drug’s potential to effectively address this challenging condition. With its strong clinical results and focus on improving multiple aspects of fibromyalgia, TNX-102 SL offers hope for patients seeking better management of their symptoms and represents a significant advancement in the treatment landscape for this debilitating disorder.

Market Opportunity

From an investment perspective, Tonix Pharmaceuticals is strategically positioned to capitalize on the growing demand for effective treatments in the central nervous system (CNS) disorder market, particularly within the fibromyalgia segment, which is estimated to affect up to 10 million people in the U.S. alone. With the potential approval of TNX-102 SL, Tonix could tap into a significant and underserved market, offering a non-opioid alternative for a condition that currently has limited treatment options. The recent positive results from the Phase 3 trials and the FDA’s Fast Track designation increase the likelihood of TNX-102 SL gaining market approval, which could significantly boost Tonix’s market share and revenue potential.

In addition to its lead candidate, Tonix’s diversified pipeline, which includes treatments for conditions such as cocaine intoxication and autoimmune diseases, broadens market opportunities and reduces single product dependency. The company’s established commercial presence with its migraine treatments, combined with the advancement of its CNS and immunology portfolios, positions Tonix to become a key player in the biopharmaceutical industry. As the company moves closer to potential product launches and reached new clinical milestones, it stands to attract substantial investor interest, offering significant upside potential as it addresses critical unmet needs across multiple therapeutic areas.

Leadership Team

Dr. Seth Lederman is the Co-Founder, CEO, and Chairman of Tonix Pharmaceuticals, bringing decades of experience in the biotechnology and pharmaceutical industries. A trained physician and scientist, Dr. Lederman has been instrumental in leading Tonix’s strategic direction and advancing its pipeline of innovative therapeutics. He has a strong background in immunology and infectious diseases, with numerous contributions to medical research and drug development. Dr. Lederman earned his MD from Columbia University, where he also served as an Associate Professor.

Dr. Gregory Sullivan is the Chief Medical Officer of Tonix Pharmaceuticals, where he oversees the clinical development and regulatory strategy for the company’s therapeutic programs. With extensive experience in psychiatry and CNS disorders, Dr. Sullivan plays a key role in guiding Tonix’s clinical trials and ensuring the scientific rigor of its development efforts. Before joining Tonix, Dr. Sullivan had a distinguished career in academic medicine and clinical research. He holds an MD from the University of California, San Francisco, and has published widely on topics related to psychiatry and neurological disorders.

Additional Resources

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), closed Monday's trading session at $13.47, up 3.4562%, on 10,406 volume. The average volume for the last 3 months is 2,077,891 and the stock's 52-week low/high is $6.76/$1216.

Recent News

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

McEwen Mining (NYSE: MUX) (TSX: MUX) has acquired approximately 5.4% of Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) through a strategic non-brokered private placement. The transaction involved McEwen purchasing 5,181,347 units of Goliath at C$1.93 per unit in exchange for 868,056 McEwen shares valued at C$11.52 each. McEwen Chairman Rob McEwen, who now personally holds 3.9% of Goliath on a partially diluted basis, praised the company's high-grade Surebet gold discovery, where 92% of drill holes in 2024 contained visible gold. The investment includes a standstill agreement preventing McEwen from exceeding 9.9% ownership for two years without Goliath's approval.

To view the full press release, visit https://ibn.fm/01JB9

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 8th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions of the Americas. The company proactively took cost-saving measures months ago to lower expenses and increase production across its portfolio of gold assets, driving some production costs below industry averages. Gold and copper prices, already in an upswing, are forecast to enter an explosive uptrend over the next couple years. Drawing from its experience, McEwen Mining planned, prepared and laid the groundwork to capitalize on this emerging opportunity.

The company currently holds a Zacks Rank #1 (Strong Buy), placing it in the top 5% of over 4,000 stocks ranked by Zacks, based on trends in earnings estimate revisions and EPS surprises. Seldom is management so aligned with investors’ interests and committed to the company’s success. With a combined investment of over $220 million, CEO Rob McEwen holds a 17% ownership stake in McEwen Mining and a 13% ownership in McEwen Copper. Acclaimed in the mining industry, McEwen founded Goldcorp, where he increased the company’s market capitalization 160 times – from $50 million to over $8 billion. That same vision and tenacity led MUX in creating McEwen Copper.

For McEwen Mining shareholders, beyond the company’s exposure to gold upsurges, its 47.7% stake in McEwen Copper is expected to be a blockbuster, turbocharging MUX by creating the world’s next prolific copper unicorn.

McEwen Copper

With continuous industrial need, new critical demand for copper is rapidly emerging, increasingly driven by the green energy transition. The price of copper rose from a low of about $2 per pound in 2020 to over $4.60 per pound in May 2024, and strong demand is expected to intensify. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global forecasts annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining owns a 47.7% equity stake in McEwen Copper, the holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which is ranked the 8th largest undeveloped copper deposit in the world. Current copper resources at Los Azules are estimated at 10.9 billion pounds at a grade of 0.40% Cu (Indicated category) and an additional 26.7 billion pounds at a grade of 0.31% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, USA, called Elder Creek.

In a 2023 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 27-year life, producing an average of 322 million lbs. of copper cathode annually, at a cash cost of $1.07 per lb. of copper, in the lowest quartile of the copper cost curve. The project could ultimately become an even larger mine with a longer life, since the extent of mineralization has not been fully assessed on the property.

The project’s 2023 PEA presents a distinctly different development strategy from a prior PEA published in 2017. By proposing a heap leach project using solvent extraction-electrowinning instead of the previously detailed mine with a conventional mill and flotation concentrator, McEwen Copper aims to decrease its environmental footprint and reduce permitting risk, albeit with a lower overall copper recovery, slightly higher unit costs and a delay in immediate cashflow due to extended leach cycles.

After securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC, McEwen Copper closed its non-brokered, private placement offering of $82 million in August 2022. Shortly after, in February 2023, Nuton agreed to invest an additional $30 million into McEwen Copper, and in October 2023, Nuton once again expanded its stake, investing an additional $10 million to bring its ownership position in McEwen Copper to 14.5%.

“We are extremely pleased to have Nuton’s strong continued participation in McEwen Copper,” Rob McEwen stated in a news release. “Together we are exploring new technologies that save energy, water, time and capital in the pursuit of delivering green copper to Argentina and the world, a product that will contribute to the electrification of transportation and the protection of our atmosphere.”

Also in February 2023, FCA Argentina S.A., a subsidiary of Stellantis N.V., one of the world’s leading automakers, invested ARS $30 billion in McEwen Copper. In October 2023, Stellantis invested an additional ARS $42 billion, bringing its current stake in McEwen Copper to 19.4%.

“We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” Rob McEwen said of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that can achieve net-zero carbon emissions by 2038.”

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project, with a Feasibility Study planned for Q1 2025. MUX strategically reduced its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver assets.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release.

McEwen Mining issued 2024 guidance for its cash cost/oz at the Fox Complex of $1,225-1,325 on annual production of 40,000-42,000 GEOs. Fox Complex produced 44,450 GEOs in 2023, which was within the company’s guidance range.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have yielded over 1,000,000 ounces of gold to date. Also, the complex includes the Grey Fox and Stock deposits that have over 1,800,000 ounces in gold resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, with a total gold content currently estimated at over 300 million ounces.

In 2024, MUX commenced development of underground ramp access to the Stock orebodies at the Fox Complex. This development will become the primary source of feed following the completion of mining the Froome deposit in 2026. As part of the future mining sequence initiative, the company has already reported a 31% year-over-year increase of gold resources at Stock West and Stock Main (historical Stock Mine), with confirmation of good grading structures plunging to depth. It has also identified Stock East as a potential new near-term source of future revenue.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine, located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure, 25 miles south of Nevada Gold Mines, a Barrick-Newmont joint venture, part of the Cortez-Goldrush complex. This complex contains estimated reserves and resources of over 50 million gold ounces, with an annual production of 1,000,000 gold ounces.

Gold Bar had been mined between 1991 and 1994, producing 134,000 gold ounces. A new facility was built by MUX in 2019. Gold Bar accounted for 42,700 GEOs in 2023, within the company’s guidance for the year. For 2024, McEwen Mining issued guidance of 40,000-43,000 at a cash cost of $1,450-1,550. The first half of the year is expected to deliver higher production relative to the second half, due to a scheduled waste stripping phase in the Pick pit, in preparation for the 2025 mining program.

Notably, in April 2024, McEwen Mining announced its entry into a definitive agreement and plan of merger with Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS) in a transaction valued at roughly $18.8 million. The merger with Timberline is expected to augment McEwen’s existing portfolio of development and exploration projects in Nevada, leveraging synergies between Timberline’s projects and the Company’s Gold Bar mine.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX began operating it as an open pit, heap leach mine in 2013, which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. Due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018 and residual heap leaching followed until mid-2022. The redevelopment plan envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material, then transition to open pit mining and processing of the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to begin in the second half of 2024.

San José Mine

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine, located in Santa Cruz province, Argentina, encircling Newmont’s prolific Cerro Negro (approx. 300,000 gold ounces produced in 2023). This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 296 gpt silver and 5.4 gpt gold.

Exploration is continuing to extend high-grade veins and discover new veins at the complex. San José’s drilling programs to define additional resources and reserves have a long history of success due to a high vein density, aided by good geophysical response from hidden veins.

Production guidance for 2024 for MUX’s 49% interest is 50,000-60,000 GEOs. As a minority shareholder in the mine, MUX equity accounts for its investment in San José, and receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks suffered significant losses in the wake of the COVID-19 pandemic. However, this has turned, and many analysts now forecast a gold bull market in 2024 and beyond.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director of Operations for America and Mexico. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Monday's trading session at $6.99, off by 2.2378%, on 1,947 volume. The average volume for the last 3 months is 1,262,827 and the stock's 52-week low/high is $6.4556/$12.5.

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

Knightscope (NASDAQ: KSCP) announced the renewal of four Autonomous Security Robot (ASR) subscription agreements, seven new ASR deployments, and sales contracts for 96 Emergency Communication Devices (ECDs), totaling 107 active machines and devices. The ASR renewals span the healthcare, automotive lubricants, and logistics sectors, while new deployments include clients such as Forbes Todd Automotive and Phenix City's local government. Additionally, three higher education campuses have invested in Knightscope's ECDs through Transportation Solutions & Lighting (TS&L) to enhance campus safety with K1 Blue Light Towers and E-Phones. The increasing adoption of Knightscope's AI-powered security solutions highlights growing confidence in its technology.

To view the full press release, visit https://ibn.fm/fZelI

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at www.knightscope.com/crime

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at www.knightscope.com/investors

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at www.knightscope.com/ksoc

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at www.knightscope.com/roadshow

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Monday's trading session at $4.7, off by 7.8431%, on 288 volume. The average volume for the last 3 months is 226,158 and the stock's 52-week low/high is $4.58/$31.5.

Recent News

Greenwave Technology Solutions Inc. (NASDAQ: GWAV)

The QualityStocks Daily Newsletter would like to spotlight Greenwave Technology Solutions Inc. (NASDAQ: GWAV).

Greenwave Technology Solutions (NASDAQ: GWAV) announced significant margin expansion driven by a 20% rise in scrap steel prices since early February, with further increases expected as U.S. steel and aluminum import tariffs take effect on March 12, 2025. Through its wholly owned subsidiary, Empire, Greenwave operates Hampton Roads' leading scrap metal chain, supplying major defense contractors and the world's largest naval base with military-grade scrap metal. The company runs 13 metal recycling facilities across Virginia, North Carolina, and Ohio, serving industry giants such as Nucor, Sims, and Cleveland-Cliffs. Greenwave's competitive positioning is further strengthened by a portfolio of protected operational licenses, key facility acquisitions reducing rental costs, and its role as a major supplier to Nucor's upcoming steelmaking facility in North Carolina.

To view the full press release, visit https://ibn.fm/M8gpP

Greenwave Technology Solutions Inc. (NASDAQ: GWAV), through its wholly owned subsidiary Empire Services Inc., operates a network of 13 metal recycling facilities located across Virginia, North Carolina, and Ohio. These facilities specialize in the collection, classification, and processing of raw scrap metal, both ferrous and nonferrous. By efficiently managing and repurposing scrap metal, Greenwave plays a crucial role in the recycling industry, contributing to the sustainability and conservation of natural resources.

Steel, one of the most recycled materials globally, can be re-melted and re-cast multiple times without losing its properties. Greenwave’s facilities are instrumental in ensuring that scrap steel and other metals are effectively recycled, reducing the need for virgin materials and minimizing the environmental impact associated with metal production. The company’s operations not only support the circular economy but also provide essential raw materials for various industries.

As a leader in metal recycling, Greenwave Technology Solutions is committed to expanding its operations and enhancing its capabilities to meet the growing demand for recycled materials. Through continued investment in technology and infrastructure, the company aims to improve its processing efficiency, lessening environment impact and improving economies.

Scrap App

Greenwave Technology Solutions recently achieved a significant milestone with its wholly-owned subsidiary, Scrap App Inc., setting a new weekly revenue record from cars purchased through its ScrapApp.com platform between July 21 and July 27, 2024. Scrap App, launched recently in the Greenville, North Carolina, market, makes selling junk cars simple and seamless on a user-friendly platform where customers can quickly and easily sell their vehicles. This success underscores Greenwave’s strategy of leveraging vertical integration to create efficiencies in the car scrapping process, positioning Scrap App for continued growth and competitive advantage in the $42.2 billion scrap metal industry.

In addition to simplifying the car-selling process, Scrap App has implemented Trust Pilot reviews to enhance its Google search ranking and optimize its conversion rate, further boosting its market presence. With hundreds of thousands of dollars already generated from car purchases, Greenwave plans to expand Scrap App into several new markets in the coming weeks. The company aims to develop Scrap App into a leading technology platform, capitalizing on the efficiencies and scalability created by its integration with Greenwave’s existing metal recycling operations, and establishing a strong foothold in the competitive scrap metal industry.

Market Opportunity

From an investment perspective, Greenwave Technology Solutions is well-positioned to capitalize on the growing demand for sustainable metal recycling, driven by increasing environmental awareness and regulatory pressures to reduce carbon emissions. As industries worldwide shift towards greener practices, the metal recycling sector is experiencing robust growth, with recycled materials becoming a preferred choice for manufacturing due to their lower environmental impact. Greenwave’s established network of 13 metal recycling facilities in key markets positions the company to benefit from this trend, offering a stable revenue base with potential for expansion as the demand for recycled metals continues to rise.

Additionally, the integration of technology through Scrap App presents a significant growth opportunity for Greenwave. As the scrap metal industry, valued at $42.2 billion, becomes more digitized, platforms like Scrap App, which streamline the car scrapping process, can capture substantial market share by providing convenience and efficiency to consumers. Greenwave’s focus on scaling Scrap App across new markets not only diversifies its revenue streams but also enhances its competitive edge by leveraging technology to optimize operations and customer engagement. This dual strategy of combining traditional recycling with innovative digital solutions positions Greenwave as an attractive investment opportunity with strong growth potential in a rapidly evolving industry.

Leadership Team

Danny Meeks, Chairman and CEO of Greenwave Technology Solutions, began his entrepreneurial journey at the age of 18 with a single truck, quickly expanding his hauling company by reinvesting its profits. Within two years, he secured contracts for some of the region’s largest projects, including the Chesapeake Bay Bridge-Tunnel expansion. A seasoned businessman, family man, and active community member, Mr. Meeks leverages his unique skills and experiences to drive Greenwave’s growth and success.

Isaac Dietrich, Chief Financial Officer of Greenwave Technology Solutions, is the founder of the company and has held various key leadership roles, including CEO and Chairman of the Board. He has been instrumental in securing over $100 million in equity financing, developing a robust shareholder base of more than 27,000 investors, and overseeing an acquisition that led to $33.9 million in revenue in fiscal year 2022. Mr. Dietrich also serves on the Board of Directors of Truleum Inc., where he chairs the Audit Committee.

Additional Resources

Greenwave Technology Solutions Inc. (NASDAQ: GWAV), closed Monday's trading session at $0.2776, up 4.6363%, on 25,037 volume. The average volume for the last 3 months is 6,096,089 and the stock's 52-week low/high is $0.2333/$89.49.

Recent News

FAVO Capital Inc. (OTC: FAVO)

The QualityStocks Daily Newsletter would like to spotlight FAVO Capital Inc. (NASDAQ: FAVO).

FAVO Capital Inc. (OTC: FAVO) is redefining the private credit and alternative lending industry through a strategic redevelopment of its operations and offerings. With a focus on leveraging financial technology and a client-centric approach, FAVO Capital empowers small to medium-sized businesses with fast, flexible, and reliable access to capital, bridging the gap left by traditional financial institutions.

Empowering Businesses, Redefining Private Credit

As part of its strategy to uplist to Nasdaq, FAVO Capital is enhancing its technology platform, operational scalability, and market positioning to meet higher regulatory standards and attract institutional investors. Headquartered in Fort Lauderdale, Florida, FAVO employs over 120 professionals across five global offices, delivering sustainable growth and value for clients and shareholders alike.

Products and Services

  • Proprietary Lending Platform and Mobile App (In Development): FAVO Capital is in the early stages of developing an advanced digital platform designed to enhance client engagement and streamline funding processes. This platform will eventually allow businesses to apply for funding products, track progress, and manage repayment efficiencies. A complementary mobile app is also being planned to provide real-time insights and tailored recommendations, laying the groundwork for an improved borrower experience.
  • Fintech-Driven Lending Solutions: FAVO Capital is exploring proprietary and third-party technology tools, including advanced analytics and algorithms, to enhance decision-making speed and reliability in the lending process.
  • Flexible Financing Options: FAVO specializes in structuring customized capital solutions tailored to the diverse needs of small business owners, offering scalable and adaptable products that evolve with changing market conditions.

Market Opportunity

The private credit market is experiencing exponential growth as traditional banks reduce their focus on small business lending. According to industry reports, the global private credit market is projected to surpass $1.5 trillion by 2025, driven by increasing demand for alternative financing options.

FAVO Capital is uniquely positioned to capture market share within this booming sector by leveraging fintech innovation to meet the needs of underserved small businesses. With a focus on efficiency, speed, and client satisfaction, FAVO addresses critical gaps in the financial ecosystem while building a platform for long-term growth.

Recent Highlights

  • Fintech Innovation: Initial investments in app development and analytics lay the groundwork for future operational efficiency and improved borrower experience.
  • Operational Scale: A global footprint with over 120 employees combines the agility of a local lender with the reach of an international financial institution.
  • Proven Growth: FAVO’s technology-driven approach has enabled consistent expansion, solidifying its reputation as a trusted partner for small businesses.

Leadership Team

Vincent Napolitano is a Founder and CEO of FAVO Capital Inc. With over two decades of experience in finance and business development, Vincent has been instrumental in building FAVO Capital into a trusted partner for businesses seeking innovative financial strategies. Prior to founding FAVO Capital, Vincent spent 25 years on Wall Street, holding key positions at prominent firms and developing expertise in structuring complex financial deals. He also served as Chief Investment Officer for multiple special purpose vehicles (SPVs), acquiring private stock in pre-IPO unicorn companies such as Facebook and Twitter.

Shaun Quin is a Founding Member and President of FAVO Capital Inc., overseeing the company’s mission to deliver innovative and efficient private credit solutions to small and medium-sized businesses. With over 20 years of global experience as a partner, investor, and director, Shaun brings a strategic and customer-focused approach to his leadership. His expertise in fostering collaboration, building high-performance cultures, and empowering businesses has positioned FAVO Capital as a trusted leader in private lending.

Vaughan Korte, CFO, brings over 15 years of global financial expertise to his role with FAVO Capital Inc. His track record includes managing financial operations for Adidas across 60 countries with budgets exceeding $500 million. Vaughan’s leadership ensures FAVO Capital remains financially resilient, aligning financial strategy with organizational goals and fostering shareholder value.

Glen Steward, Chief Strategy Officer, is a seasoned entrepreneur with over 28 years of experience in the investment and trading industries. He drives FAVO Capital’s strategic initiatives, ensuring the company remains competitive and agile in a rapidly evolving market. Glen has held directorships and board memberships across Mauritius, South Africa, and the United States. His strategic acumen has been pivotal in integrating the FAVO Group of Companies into FAVO Capital Inc., fueling growth and market leadership.

Advisory Board

Bilal Adam, Accounting & Financial Counsel, is a financial expert with over 20 years of experience, including roles as CEO of Stewards Investment Capital. His insights into bespoke investment solutions, including fixed income, equity, and digital assets, support FAVO Capital’s innovative approach to private credit.

Honorable Earnest Hart, Corporate Governance Counsel, brings decades of legal and governance experience, having served as a New York Supreme Court Judge and COO at Columbia University Medical Center. His guidance ensures FAVO Capital maintains robust corporate governance standards.

Rocco Trotta, Business Leadership and Scalability Counsel, is the co-founder of LiRo-Hill and has decades of experience scaling businesses. His expertise in organizational efficiency and talent development strengthens FAVO Capital’s ability to attract excellence across all aspects of the business.

As FAVO Capital redevelops its operations and prepares for an uplisting to Nasdaq, the company is laying the foundation to redefine private credit with emerging fintech solutions and exceptional leadership. Learn more by visiting investors.favocap.com.

Investment Considerations
  • Early-Stage Technology Development: Laying the groundwork for proprietary platforms and scalable digital tools.
  • Significant Market Opportunity: The private credit market is projected to exceed $1.5 trillion by 2025, providing exponential growth potential.
  • Scalable Business Model: Automated processes and data-driven decision-making enable rapid scaling with minimal overhead.
  • Customer-Centric Approach: FAVO’s focus on small businesses and flexible financing solutions addresses critical gaps in the financial ecosystem.
  • Experienced Leadership: A forward-thinking executive team ensures strategic growth and innovation.

FAVO Capital Inc. (OTC: FAVO), closed Monday's trading session at $0.9999, even for the day, on 1,026 volume. The average volume for the last 3 months is 4,540 and the stock's 52-week low/high is $0.162/$1.08.

Recent News

Starco Brands Inc. (OTCQB: STCB)

The QualityStocks Daily Newsletter would like to spotlight Starco Brands Inc. (OTCQB: STCB).

Starco Brands Inc. (OTCQB: STCB) is a modern-day invention factory. The company’s unwavering mission is to invent and acquire consumer products and brands with behavior-changing technologies that spark excitement in the everyday.

This consumer product company has grown from a few million dollars in revenue to a current run rate of approximately $67 million in annual revenue in one year.

The company has succeeded by identifying whitespaces in eight core consumer categories and then either: 1) leveraging its internal R&D capabilities and dedicated manufacturing network to invent new technologies and brands or 2) utilizing the management team’s extensive M&A experience to acquire brands that fill the industry void, delighting consumers and retailers alike.

Whether the brand is developed internally or acquired, the company employs a modern marketing playbook to ensure its brands are at the forefront of culture; garnering unprecedented media attention and engagement that supports a robust sales network.

Starco Brands’ core competencies are inventing technologies, acquiring companies, marketing, building trends, pushing awareness, penetrating media (social and otherwise) and executing cutting edge pull-through strategies with a roster of globally recognized celebrities, influencers and media and distribution partners.

A commitment to changing the way people approach everyday activities is innate in the company’s corporate DNA.

The company is based in Santa Monica, California.

Brands

Whereas other consumer products companies are content with evolution, Starco Brands has its mind set on creating a revolution across the industry. From disrupting the spirits industry with Whipshots, the world’s only vodka-infused whipped cream, to Soylent, the original food tech company, Starco Brands is putting the CPG world on notice. Its portfolio of brands includes:

  • Whipshots is a first-of-its-kind alcoholic whipped cream launched in 2021 with celebrity partner Cardi B. Consumers have embraced this boozy concoction, putting it on top of cocktails, coffees and desserts, or enjoying it straight from the can. In just over a year, the brand has sold over 2 MILLION cans, making it one of the fastest growing spirits in history.
  • Winona Pure gives consumers movie theatre popcorn in the comfort of their own homes. All the flavor and none of the additives is the story behind these all-natural, non-GMO popcorn seasoning sprays. A simple spray is all it takes to add the perfect pop of flavor to the classic theatre treat.
  • Art of Sport, co-founded by the great Kobe Bryant, is the number one body care brand for athletes. With a growing line of personal care products tested by the world’s greatest athletes, these daily skin essentials give consumers everything they need to feel fresh, stay protected and confident and perform at their peak every day.
  • Skylar is the first and only line of perfumes on the market that are hypoallergenic and safe for sensitive skin. With the strong support of industry titan Sephora, the brand has quickly attracted a loyal following.
  • Soylent is a technological feat. Originally funded by Google Ventures and Andreessen Horwitz, Soylent is dubbed as the world’s most perfect food. Made from sustainably grown plant-based ingredients, Soylent’s line of products is scientifically developed to provide all the functional ingredients, vitamins, minerals, fats, carbohydrates and protein that the body needs – all in convenient, delicious and affordable packages. Soylent’s innovative product line-up includes complete nutrition powders, ready-to-drink shakes, 100-calorie snack bars, high protein nutrition shakes and energy boosting nutrition shakes. Soylent was also the recipient of the 2023 Product of the Year Award by Kantar, a global leader in consumer research.

With award-winning marketing talent, Starco Brands develops robust, integrated marketing plans for every brand in its portfolio, ensuring an impactful presence across all verticals.

Market Outlook

Starco Brands’ varied brand portfolio gives it access to the growth of numerous product categories that are ripe for innovation.

Through its February 2023 acquisition of complete nutrition pioneer Soylent, Starco Brands is positioned to capitalize on the projected growth of the plant-based nutrition space. Research firm Statista valued the plant-based nutrition market at $29.4 billion in 2020 and forecasts its value at nearly $162 billion by 2030, representing a CAGR of 18.7% for the period.

Likewise, Starco Brands gained improved access to the global fragrance market through its December 2022 acquisition of Skylar. According to a report by Grand View Research, the global perfume market was valued at $50.85 billion in 2022 and is expected to grow to a value of nearly $80 billion by 2030, achieving a CAGR of 5.9% over the forecast period.

The company is primed to expand its access to other growth verticals as it advances on its path to invent and acquire behavior-changing technologies and brands.

Management Team

Ross Sklar is the CEO of Starco Brands. A chemical formulator by trade, he started his first company while still in college. Since 2004, he has made over a dozen acquisitions with multiple exits and controls an eclectic collection of industrial, household, personal care and food and beverage manufacturers covering many consumer-packaged goods categories.

Darin Brown is the Chief Operating Officer of Starco Brands. With over 20 years of experience in chemical manufacturing, business development, finance and mergers and acquisitions, he has scaled the company from the ground up. He oversees all internal operations for Starco Brands and is an integral liaison between the company and Mr. Sklar’s manufacturing facilities.

David Dreyer is Chief Marketing Officer of Starco Brands. With over 25 years of experience working with blue chip and startup brands, he oversees all marketing initiatives for the company. Mr. Dreyer comes to Starco having worked with such standout brands as Apple, Pepsi, Pizza Hut, Dr Pepper, Snapple, Infiniti, The GRAMMY’s, Honda and Stamps.com. He is also a Professor of Advertising at USC’s Annenberg School for Communication.

Starco Brands Inc. (STCB), closed Monday's trading session at $0.043, up 7.5%, on 32,300 volume. The average volume for the last 3 months is 72,910 and the stock's 52-week low/high is $0.0393/$0.159.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Monday's trading session at $0.0367, up 3.0899%, on 1,000 volume. The average volume for the last 3 months is 136,730 and the stock's 52-week low/high is $0.03095/$0.1164.

Recent News

Brera Holdings PLC (NASDAQ: BREA)

The QualityStocks Daily Newsletter would like to spotlight Brera Holdings PLC(NASDAQ: BREA).

Brera Holdings PLC (NASDAQ: BREA) is an Ireland-based, international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership approach. The company capitalizes on opportunities to earn tournament prizes, secure sponsorships, collect transfer fees, provide professional sports consulting services, and enhance the valuation of its clubs.

Brera Holdings builds on the legacy of Brera FC, an international football club (referred to as soccer in the U.S.), that it acquired in July 2022. Established in 2000 and based in Milan, Italy, Brera FC has distinguished itself by cultivating an alternative football legacy. In October 2024, the Internet Marketing Association awarded Brera FC with the Social Impact Through Soccer accolade at its IMPACT 5050 Conference, recognizing the club’s global perspective and positive contributions to society.

The company’s growth strategy focuses on unlocking value from undervalued sports clubs and talent, driving innovation, and generating socially impactful outcomes. Brera Holdings is actively expanding its Global Sports Group, acquiring professional football and other sports clubs in emerging markets such as Africa, Asia, and Europe.

By targeting top-division teams in less mainstream markets, Brera Holdings aims to strengthen its competitive position in regional tournaments, including those organized by the Union of European Football Associations (UEFA). These acquisitions are expected to enhance sponsorship revenues and create new growth opportunities.

Leveraging its expertise in capital raising and revenue generation, Brera Holdings also anticipates growing demand for its consulting services, providing advisory support to sports clubs, associations, investors, and others. Brera Holdings is headquartered in Dublin, Ireland, with additional offices in Milan, Italy.

Sporting Assets

Brera Holdings continues to grow its global sports portfolio with a series of strategic acquisitions and innovations, including the FENIX Trophy Tournament, a pan-European, non-professional football competition. Launched in September 2021 and organized by Brera FC, the tournament has been recognized by UEFA and described by BBC Sport as “the Champions League for amateurs.” In 2023, Brera FC hosted the tournament’s finals at Milan’s iconic San Siro Stadium.

In March 2023, Brera Holdings expanded into Africa by establishing Brera Tchumene FC in Mozambique. Starting in the country’s Second Division League, the team quickly earned promotion to Moçambola, Mozambique’s First Division League, by November 2023.

In April 2023, Brera Holdings further strengthened its European presence by acquiring a 90% stake in Fudbalski Klub Akademija Pandev, a first-division football team in North Macedonia. This acquisition provides access to two major UEFA competitions, solidifying the company’s position in European football.

Brera Holdings’ reach extends beyond football. In July 2023, it acquired majority ownership of UYBA Volley, an Italian Serie A1 women’s professional volleyball team, demonstrating its commitment to diversifying within top-tier sports.

In September 2023, Brera Holdings entered the Mongolian football market by acquiring Bayanzurkh Sporting Ilch FC, a Mongolian National Premier League team. For the 2024 season, the club was rebranded as Brera Ilch FC, further expanding Brera’s global footprint.

In January 2024, Brera Holdings initiated a proactive search for an Italian Serie B football club, aligning with its goal of bringing multi-club ownership opportunities to mass investors through its Nasdaq-listed shares.

In February 2024, the Brera Holdings Advisory Board was established with MLS founder and World Cup director Alan Rothenberg, luxury lifestyle executive Massimo Ferragamo, sports business leaders Paul Tosetti and Marshall Geller, and Italian football icon Giuseppe Rossi.

In June 2024, the North Macedonian women’s football club Tiverija Strumica officially became part of the Brera family with the establishment of a joint-stock company controlled by Brera Holdings called Women’s Football Club Tiverija Brera AD Strumica (“Brera Tiverija”). Brera Tiverija is now a wholly-owned subsidiary of Brera Strumica FC.

In September 2024 Brera announced that it signed an exclusive letter of intent to acquire an Italian Serie B club (the “LOI” and the “Club”). According to a CFA report published in June 2024, this expected strategic transaction, for an estimated purchase price of $21.6 million, would add first-year annual revenue of $10.8 million to Brera, and that revenue would likely increase by 25% each year for the next three years. The company’s capital valuation, projected the report, would also experience significant appreciation during this period.

In October 2024, Brera was recognized with the 2024 Social Impact Through Soccer Award at IMPACT 5050, an annual event honoring leaders and innovators who significantly impact their industries and communities. This is the second time Brera has won the award.

Market Opportunity

A report from IMARC Group, a global management consulting firm, reveals that the international football market generated approximately $3.3 billion in revenue in 2023, with projections to grow to $4.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 3.6%. Key drivers behind this growth include advancements in digitization, increasing sponsorship and partnership deals between brands and clubs, the rising interest in women’s professional soccer leagues, and the expansion of the e-sports and gaming sector.

In particular, Serie B Italian football clubs seem to present exceptionally attractive investment opportunities. As of September 2024, more than half of these clubs had appreciated between 80-100% in total market value, post-purchase.

As the world’s most-watched and most-played sport, soccer drives significant demand for football-related products and services, contributing to market growth. Broadcasting rights, sponsorships, and endorsement deals are also major revenue sources for clubs and organizations, with an expanding global fanbase generating new opportunities for financial growth, according to the report.

Management Team

With extensive experience in leadership and finance, Daniel McClory currently serves as the Executive Chairman and Director of Brera Holdings, PLC. He co-founded and held the position of Chief Executive Officer at Boustead & Company Limited, and previously served as the Managing Director, Head of Equity Capital Markets, and Head of China at Boustead Securities, LLC. Mr. McClory’s governance experience includes being a Board Director for USA Track & Field and a member of the Eastern Michigan University Champions Advisory Board. Mr. McClory’s expertise encompasses founding and financing equity capital markets, as well as navigating merger and acquisition transactions and initial public offerings. He holds a BS and MS from Eastern Michigan University, where he also received an honorary Doctor of Public Service. In addition to his professional qualifications, he is fluent in both English and Italian.

Pierre Galoppi serves as the CEO, Interim CFO, and director of Brera Holdings. With over 30 years of experience in strategic business and financial services, his career spans a variety of industries, including natural resources, aviation, cybersecurity, telecommunications, tourism, and international marketing. He has worked extensively across Latin America, the Caribbean, Canada, Europe, and the United States. Mr. Galoppi holds dual citizenship in Canada and Italy and is fluent in English, Spanish, Portuguese, Italian, and French. He earned a Bachelor of Commerce degree and an MBA from Concordia University in Montreal.

Maria Xing serves as the Head of Investments and Corporate Development. She is an executive who has specialized in MCO football (soccer) group investments for 777 Partners, where she was involved in sourcing, direct negotiations, due diligence, and closing deals, including acquiring a controlling stake in Brazilian Serie A football club, Vasco da Gama, and investing in Australian Premier League (“A-League”) side, Melbourne Victory FC. She also played a role in other professional sports franchise portfolio management, including topflight professional football clubs in Italy, France, Germany, and Belgium. Her background is in private equity, investment banking, and finance, with prior experience at The Raine Group, Credit Suisse, and EY (Ernst & Young), as well as previous sports industry experience at Liverpool Football Club in international business development. Ms. Xing earned an MBA from the Wharton School of the University of Pennsylvania and a B.S. from the New York University, Stern School of Business.

Additional Resources

Brera Holdings PLC (NASDAQ: BREA), closed Monday's trading session at $0.765, up 24.37%, on 2,990 volume. The average volume for the last 3 months is 3,430,337 and the stock's 52-week low/high is $0.4999/$1.95.

Recent News

NEWTON GOLF Company (NASDAQ: SPGC)

The QualityStocks Daily Newsletter would like to spotlight NEWTON GOLF Company (NASDAQ: SPGC).

NEWTON GOLF Company (NASDAQ: SPGC), a Sacks Parente Company, is a technology-forward golf equipment manufacturer committed to enhancing player performance through innovative design. Since its founding in 2018, the company has developed a growing portfolio of premium golf products, including putters, golf shafts, grips, and related accessories. Its proprietary advancements include the First Vernier Acuity putter, patented Ultra-Low Balance Point (ULBP) technology, weight-forward Center-of-Gravity (CG) design, and ultra-light carbon fiber putter shafts.

As part of its commitment to growth in golf shaft technologies, the company expanded its manufacturing operations in April 2022, opening a dedicated facility in St. Joseph, Missouri. This move reinforced its goal of maintaining high-quality production standards while manufacturing and assembling substantially all of its products in the United States. In addition to golf clubs and accessories, NEWTON GOLF is exploring expansion into golf apparel and other product categories.

The company sells its products through multiple channels, including resellers, its direct-to-consumer website, Club Champion retail stores, and distributors in the U.S., Japan, and South Korea. Future expansion may include growth through mergers, acquisitions, or the development of complementary product lines.

NEWTON GOLF Company is headquartered in Camarillo, California.

Products

NEWTON GOLF is focused on delivering high-performance golf equipment with a strong emphasis on precision engineering and cutting-edge materials. The company’s key product lines include:

  • Newton Motion Golf Shafts: Launched in November 2023, these shafts are engineered with proprietary flex profiles designed for greater distance, reduced dispersion, and optimized performance across swing speeds. The company’s DOT system eliminates traditional shaft flex definitions, making it accessible to all golfers.
  • Gravity Putters: Introduced in October 2024, these putters incorporate patented Ultra-Low Balance Point (ULBP) technology to improve stroke consistency and tighten putt dispersion. Manufactured in the U.S., they feature premium materials such as steel, aluminum, titanium alloys, and patented magnesium face plate technology.
  • Golf Grips & Accessories: The company continues to innovate in this category, providing golfers with performance-enhancing grips and accessories to complement their clubs.

All NEWTON GOLF products are manufactured with strict quality control standards to ensure precision and reliability, reinforcing the brand’s reputation for premium performance.

Market Opportunity

The global golf equipment market was valued at approximately $8 billion in 2022, with the U.S. market accounting for $2.9 billion. The golf club segment dominated the industry, representing 45.7% of total market share. Increasing participation in golf, particularly among younger players and women, is driving demand for high-quality, customizable golf equipment.

Key industry trends supporting growth include:

  • The increasing popularity of premium, high-performance golf equipment among both professionals and amateurs.
  • A shift toward customization, as golfers seek tailored products that enhance performance.
  • A growing interest in golf from younger demographics, with amateur and collegiate golfers being particularly receptive to innovation.

NEWTON GOLF’s emphasis on U.S.-based manufacturing provides it with a competitive edge in terms of supply chain efficiency, quality control, and sustainability, further strengthening its position in the market.

Leadership Team

Dr. Greg Campbell, Executive Chairman and Chief Executive Officer, brings nearly 40 years of experience in emerging technologies, product development, and public company leadership. He currently serves as CEO of V-Grid Energy Systems, a California-based company focused on converting agricultural waste into renewable electricity and bio-carbon. He has successfully taken two companies public and previously managed a $1.2 billion P&L as SVP & GM at Lam Research. Campbell holds a Ph.D. in Electrical and Electronics Engineering from UCLA and a BA/MA in Engineering from Cambridge University.

Ryan Stearns, Chief Financial Officer, was appointed in 2024 and oversees financial planning and corporate strategy. He brings expertise in scaling businesses and optimizing financial performance to support the company’s growth.

Investment Considerations
  • NEWTON GOLF Company operates in a large and expanding global golf equipment market with rising demand for high-performance products.
  • The company benefits from strong gross margins and a clear pathway to profitability as it scales its operations.
  • U.S.-based manufacturing provides strict quality control, supply chain efficiency, and faster response times to market demand.
  • An omnichannel sales strategy, including retail, e-commerce, and international distribution, enhances market reach and revenue diversification.
  • Future growth opportunities include new product lines, strategic acquisitions, and continued technological advancements in golf equipment.

NEWTON GOLF Company (NASDAQ: SPGC), closed Monday's trading session at $0.1601, off by 9.3431%, on 3,648,296 volume. The average volume for the last 3 months is 28,341,700 and the stock's 52-week low/high is $0.102/$6.69.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.